Neurovascular Embolization Market Size & Share 2023 to 2032
Market Size by Product (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Aneurysm Clips, Intrasaccular Flow Disruptors), Procedure (Aneurysm Coiling & Embolization, AVM Embolization), End Use – Global Forecast.
Report ID: GMI7160
|
Published Date: October 2023
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Neurovascular Embolization Market Size
Neurovascular Embolization Market size was valued at USD 1.4 billion in 2022 and is estimated to account for USD 2.5 billion by 2032. Neurovascular embolization is a minimally invasive procedure that uses embolic agents delivered through a catheter to treat aneurysms, arteriovenous malformations, and tumors in brain and spinal cord by blocking or reducing blood flow to the affected area.
Neurovascular Embolization Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000. Therefore, the rising prevalence of neurovascular diseases highlights the significance of neurovascular embolization as a crucial treatment, making it a key driver for the market progress.
Furthermore, research efforts dedicated to understanding neurovascular diseases and improving treatment techniques have led to the development of novel therapies. This includes new embolic agents, better imaging modalities, and alternative approaches, expanding the range of options available for physicians. Therefore, research initiatives stimulate market growth by providing new and better solutions.
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the neurovascular embolization market with procedure delays and resource shifts. Nevertheless, it heightened medical awareness, boosted funding, and expedited telemedicine adoption. Additionally, there was a rise in incidence of ruptured blister aneurysms during the pandemic which were addressed to in later stages of pandemic. Despite healthcare disruptions, the pandemic ultimately created opportunities for progress in the neurovascular devices sector, estimated to reach 7.5 billion by 2032, contingent on ongoing research and healthcare policy developments.
Neurovascular Embolization Market Trends
Ongoing technological innovations in neurovascular embolization devices have enhanced treatment outcomes and patient safety. New materials, improved imaging techniques, and the development of more precise, minimally invasive devices have made the procedure more effective and accessible. For instance, in July 2023, MicroVention, Inc., released 5-year monitoring data for their intrasaccular device, WEB, and established two new sizes (SL 7x2 and SL 6x2) for aneurysm embolization technology, broadening its applicability to various aneurysm types and sizes. Such advancements attract healthcare providers and patients to opt for neurovascular embolization.
Neurovascular Embolization Market Analysis
The market by product is categorized into embolic coils, flow diversion devices, liquid embolic agents/systems, aneurysm clips and intrasaccular flow disruptors. The embolic coils segment garnered USD 907 million revenue size in the year 2022.
Based on procedure, the neurovascular embolization market is segmented into aneurysm coiling and embolization, arteriovenous malformation (AVM) embolization, and other procedures. The aneurysm coiling and embolization segment dominated the market and accounted for over 59% business share in the year 2022.
The neurovascular embolization market by end-use is categorized into hospitals, specialty clinics, and other end-users. The hospitals garnered USD 894 million revenue size in the year 2022.
The U.S. neurovascular embolization market accounted for USD 503 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
Neurovascular Embolization Market Share
The neurovascular embolization industry is consolidated, with key players such as Medtronic, Stryker, Cerenovus (Johnson & Johnson), and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, Medtronic's pipeline flex embolization device with shield technology has received FDA approval. This technology is a notable advancement in flow diversion therapy, reducing the risk of clot formation on the device's surface and improving treatment safety and efficacy.
Some of the eminent market participants operating in the neurovascular embolization industry include:
Neurovascular Embolization Industry News:
Neurovascular embolization market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million and Units)
By Procedure, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →